MedTrace Logo

Dry Needling Versus Intramuscular Stimulation in the Management of the Myofascial Trigger Points

NCT03025230 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-05-08

No results posted yet for this study

Summary

Hypothesis The application of intramuscular electrostimulation will be more effectiveness than the dry needling in myofascial trigger points treatment.

Objetives:

To determine the effectiveness of intramuscular electrostimulation in the treatment of trigger points of the levator scapula muscle for the improvement of pain in mechanical cervicalgia.

Participants: Subjects with diagnosed of myofascial pain syndrome in cervical region and active trigger points in levator scapulae muscle, randomly assigned to experimental or control group.

Intervention: Control group: one session of dry needling in active trigger points; experimental group: one session of intramuscular stimulation in active trigger points.

Main Outcomes Measures: Pain, pressure pain threshold (PPT), active cervical range of motion and strength muscle . The measures will be taken before, after and one week after the interventions.

Conditions

  • Trigger Point Pain, Myofascial
  • Muscle Pain
  • Myofascial Pain Syndrome

Interventions

OTHER

Dry needling and electric stimulation

Dry needling technique and the application of electric stimulation of levator scapulae PG

OTHER

Dry needling

Treatment of PG with a filiform needle in levator scapulae muscle

Sponsors & Collaborators

  • University of Alcala

    lead OTHER

Principal Investigators

  • Tomás Gallego-Izquierdo, Doctor · Alcala University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-03-31
Completion
2017-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025230 on ClinicalTrials.gov